Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Pricing Zolgensma—The World’s Most Expensive Drug
by Mark Nuijten
 
Rapid Literature Review: Definition and Methodology
by Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay and Laurent Boyer
 
Artificial Intelligence and Remote Patient Monitoring in US Healthcare Market: A Literature Review
by Ayushmaan Dubey and Anuj Tiwari
 
Implementation of Equity and Access in Indian Healthcare: Current Scenario and Way Forward
by Canna Ghia and Gautam Rambhad
 
Impact of the COVID-19 Pandemic on the Conduct of Clinical Trials: A Quantitative Analysis
by Wojciech Margas, Piotr Wojciechowski and Mondher Toumi
 
The Role of Stakeholder Involvement in the Evolving EU HTA Process: Insights Generated through the European Access Academy’s Multi-Stakeholder Pre-Convention Questionnaire
by Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, Walter Van Dyck, Steven Simoens, Isabelle Huys, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G.M. Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales and Elaine Julianadd Show full author list remove Hide full author list
 
Machine-Learning Prediction for Hospital Length of Stay Using a French Medico-Administrative Database
by Franck Jaotombo, Vanessa Pauly, Guillaume Fond, Veronica Orleans, Pascal Auquier, Badih Ghattas and Laurent Boyer
 
Increased Reliance on Physician Assistants: An Access-Quality Tradeoff?
by Bhavneet Walia, Harshdeep Banga and David A. Larsen
 
Transformative Potential of Artificial Intelligence in Global Health Policy
by Ridwan Islam Sifat and Upali Bhattacharya
 
Burden of Illness Associated with Pneumococcal Infections in Japan—A Targeted Literature Review
by Ataru Igarashi, Maki Ueyama, Koki Idehara and Mariko Nomoto
Views Article
Rapid Literature Review: Definition and Methodology
by Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay and Laurent Boyer
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer and Philippe Laramée
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
by Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet and Katell Le Lay
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
by Clara Fatoye, Gillian Yeowell, Eula Miller, Isaac Odeyemi and Chidozie Mbada
Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness
by Matthias Brunner, Manjula Schou, Robert J. Briggs and Dell Kingsford Smith
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
by Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales and Jörg Ruofadd Show full author list remove Hide full author list
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
by David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing and Neil Hawkins
Welcome to the Journal of Market Access and Health Policy under MDPI Wings
by Mondher Toumi
Access to Innovative Drugs and the National Reimbursement Drug List in China: Changing Dynamics and Future Trends in Pricing and Reimbursement
by Bérengère Macabeo, Liam Wilson, Jianwei Xuan, Ruichen Guo, Petar Atanasov, Linda Zheng, Clement François and Philippe Laramée
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease
by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi and Borislav Borissov
Downloads Article
Rapid Literature Review: Definition and Methodology
by Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay and Laurent Boyer
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer and Philippe Laramée
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
by Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet and Katell Le Lay
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
by David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing and Neil Hawkins
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
by Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales and Jörg Ruofadd Show full author list remove Hide full author list
Inappropriate Dosing of Direct Oral Anticoagulants: Findings from a Clinical Vignette Study and Physician Survey
by Ahmet Fuat, Emmanuel Ako, David Hargroves, Douglas Holden, Amrit Caleyachetty, Matthew Carter, James Harris, Carol Roberts, Nnanyelu Nzeakor, Burcu Vardar and Helen Williams
Assessing the Value of Delandistrogene Moxeparvovec (SRP-9001) Gene Therapy in Patients with Duchenne Muscular Dystrophy in the United States
by Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch and Daniel C. Malone
Implementation of Equity and Access in Indian Healthcare: Current Scenario and Way Forward
by Canna Ghia and Gautam Rambhad
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
by Clara Fatoye, Gillian Yeowell, Eula Miller, Isaac Odeyemi and Chidozie Mbada
Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness
by Matthias Brunner, Manjula Schou, Robert J. Briggs and Dell Kingsford Smith
Back to TopTop